Interaction network and enrichment analysis of genes downregulated following Plx4032 treatment
Canned Analysis
FAIR Metrics
0 evaluations
General Information
| Accession | DCA00034835 |
| Title | Interaction network and enrichment analysis of genes downregulated following Plx4032 treatment |
| Description | The analysis explores the gene interaction network and pathway enrichment of the top 50 most downregulated genes identified by applying the Characteristic Direction method comparing gene expression between Plx4032 treated cells and untreated control cells in the WM164 BRAF mutant Melanoma cells cell type. |
| Analysis URL | http://genemania.org/#/search/human/ENO1|SERPINA3|IER3|MT2A|TM4SF1|HSPA8|CDK2AP1|SERPINE2|SPRY4|LDHA|HIST1H2BM|ANXA1|GAPDH|SLC43A3|PGK1|SLIRP|PKM|DHCR24|TUBB4B|SLC2A1|ACTN1|DHCR7|TUBG1|PPAP2B|SLC20A1 |
| Upload Date | September 20, 2017 |
| Uploader | maayanlab |
Metadata
| Analysis Curator | cadimo |
| CREEDS ID | drug:2556 |
| Cell Type | WM164 BRAF mutant Melanoma cells |
| Drug Name | Plx4032 |
| DrugBank ID | DB05238 |
| Organism | human |
Characteristic Direction parameters
| Gene Set | downregulated |
| Gene Set Size | 50 |
| Control Samples | GSM1322672, GSM1322673, GSM1322674 |
| Perturbed Samples | GSM1322675, GSM1322676, GSM1322677 |
Tools
used in the analysis
Datasets
used in the analysis
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.
